EVHのチャート
EVHの企業情報
| symbol | EVH |
|---|---|
| 会社名 | Evolent Health Inc （EVH エボレント・ヘルス） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 先端医療機器_テクノロジ― 工業（Industrials） |
| 概要 | 事業概要 エボレント・ヘルス(Evolent Health Inc.)は医療の提供と支払いに従事する会社である。同社は価値ベースのケアおよび人口の健康管理への移行において、保健システムおよび医師団体を支援する。同社はプロバイダー向けのエンドツーエンドのテクノロジー対応サービスプラットフォームを提供する。技術・プロセス・統合サービスによって強化された同社のプラットフォームによって、プロバイダーが個別報酬(FFS）払い戻しからバリューベースの支払いモデルに報酬を与える支払いモデルに移行することを可能にする。同社のサービスには、人口管理プラットフォーム、データと分析機能の統合、薬局給付管理（PBM）サービス、包括的な保健計画管理サービスなど、顧客に提供するサービスが含まれる。その価値に基づく操作はIdentifiによって権限を与えられ、サポートされる。Identifiは、データを集約・分析し、ケアワークフローを管理し、患者を関与させる同社のテクノロジープラットフォームである。 エボレント・ヘルスは米国のヘルスケア関連持株会社。子会社を通じ、ヘルスケア関連のソフトウエアやコンサルティングサ―ビスを提供する。支払い関連システムに注力し、顧客の価値観に基づいた支払いモデルを構築する。同社は2011年に創立され、米国全土で事業を展開する。本社所在地はバ―ジニア州ア―リントン。 Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Its solutions encompass total cost of care management, specialty care management, and administrative simplification. Evolent serves a national base of leading payers and providers, is the first company to receive the National Committee for Quality Assurance's Population Health Program Accreditation, and is consistently recognized as a top place to work in health care nationally. |
| 本社所在地 | 800 N. Glebe Road Suite 500 Arlington VA 22203 USA |
| 代表者氏名 | Frank John Williams |
| 代表者役職名 | Chairman of the Board Chief Executive Officer |
| 電話番号 | +1 571-389-6000 |
| 設立年月日 | 41974 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 3800人 |
| url | www.evolenthealth.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | EBITDA（百万ドル） -1.81400 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | 時価総額（百万ドル） 1038.68200 |
| 売上高 | 売上高（百万ドル） 627.06300 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 1031.40300 |
| 当期純利益 | 当期純利益（百万ドル） -52.95800 |
| 決算概要 | 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Evolent Health Inc revenues increased 44% to $627.1M. Net loss before extraordinary items decreased 13% to $53M. Revenues reflect Platform and operations services increase of 23% to $500.2M Transformation services increase of 12% to $32.9M. Lower net loss reflects Other Non Rec. I/E - Non Business Activ. decrease from $400K (expense) to $4.1M (income). |
EVHのテクニカル分析
EVHのニュース
Evolent Health Q1 2023 Earnings Preview 2023/05/02 21:35:56 Seeking Alpha
Evolent Health (EVH) is scheduled to announce Q1 earnings results on Wednesday, May 3rd, after market close.The consensus EPS Estimate is $0.19 (+58.3% Y/Y) and the consensus…
Evolent Health: Another Beneficiary Of Explosive Medicare Advantage Growth (NYSE:EVH) 2023/04/23 06:05:08 Seeking Alpha
Evolent began life as a software developer but 2018 acquisition of New Century Health has seen it shift into specialty care provision. Click here to read why EVH stock is a Buy.
Evolent Health to Release First Quarter Financial Results on Wednesday, May 3, 2023 2023/04/17 20:45:00 PR Newswire
Company to Also Host an Investor Day on Tuesday, May 23 WASHINGTON, April 17, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven specialty clinical solutions to payers and providers, today announced it will release its first quarter 2023…
Evolent Health, Inc - Consensus Indicates Potential 38.5% Upside - DirectorsTalk Interviews 2023/03/08 11:46:53 DirectorsTalk
Evolent Health, Inc - Consensus Indicates Potential 38.5% Upside
Evolent Health PT Raised to $63 at Cowen 2023/02/23 18:16:02 Investing.com
https://www.investing.com/news/pro/evolent-health-pt-raised-to-63-at-cowen-432SI-3012686
Evolent Health, Inc – Consensus Indicates Potential 47.4% Upside 2022/12/07 12:34:43 DirectorsTalk
Evolent Health, Inc found using ticker (EVH) have now 8 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 57 and 32 and has a mean target at 42.25. Now with the previous closing price of 28.66 this indicates there is a potential upside of 47.4%. The 50 day moving average now sits at 29.85 while the 200 day moving average is 31.04. The company has a market capitalisation of $2,759m. You can visit the company''s website by visiting: https://www.evolenthealth.com [stock_market_widget type="chart" template="basic" color="green" assets="EVH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,068m based on the market concensus. Evolent Health, a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management.
Evolent Health, Inc – Consensus Indicates Potential 52.6% Upside 2022/11/23 13:07:21 DirectorsTalk
Evolent Health, Inc found using ticker (EVH) now have 8 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 57 and 32 calculating the average target price we see 40.88. Now with the previous closing price of 26.79 this now indicates there is a potential upside of 52.6%. The 50 day moving average now sits at 31.63 and the 200 day MA is 30.87. The company has a market cap of $2,780m. You can visit the company''s website by visiting: https://www.evolenthealth.com [stock_market_widget type="chart" template="basic" color="green" assets="EVH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,242m based on the market concensus. Evolent Health, a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions.
Evolent Health: A Bit Complex, But Interesting (NYSE:EVH) 2022/11/21 10:05:22 Seeking Alpha
Evolent Health''s shares have seen a huge move higher on the back of a substantial deal. Click here to find out why the latest deal looks interesting.
This Analyst Is Bullish On Evolent Health''s Recent Deal, Calls ''Highly Strategic Acquisition'' 2022/11/18 20:01:32 Benzinga
Thursday after close, Evolent Health Inc (NYSE: EVH ) agreed to acquire Magellan Specialty Health, the specialty benefit management organization owned by Centene Corporation (NYSE: CNC ), for $650 million at the close plus additional contingent consideration of up to $150 million based on 2023 performance . William Blair is positive on the acquisition and believes this is consistent with management''s prior commentary that Evolent would consider strategic assets … Full story available on Benzinga.com
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday''s Mid-Day Session 2022/11/18 18:15:48 Benzinga
Gainers PaxMedica, Inc. (NASDAQ: PXMD ) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital. Satixfy Communications Ltd. (NYSE: SATX ) rose 53.2% to $79.20. 1847 Holdings LLC (NYSE: EFSH ) gained 27.3% to $2.0252. 1847 Holdings recently posted Q3 sales of $14.47 million. IVERIC bio, Inc. (NASDAQ: ISEE ) shares surged 25% to $21.54 after the company announced the FDA has granted breakthrough therapy designation for avacincaptad pegol for geographic atrophy. Clearfield, Inc. (NASDAQ: CLFD ) climbed 24.1% to $115.45 after the company reported better-than-expected Q4 results. Yatra Online, Inc. (NASDAQ: YTRA ) shares jumped 24.1% to $2.6299. Yatra Online''s Indian subsidiary, Yatra Online Limited, received the final observation from the Securities and Exchange Board of India. The company also announced that it will report its Q2 financial results on Tuesday, November 29, 2022. Conformis, Inc. (NASDAQ: CFMS ) gained 23.6% to $1.9540.
Evolent Health, Inc – Consensus Indicates Potential 52.6% Upside 2022/11/23 13:07:21 DirectorsTalk
Evolent Health, Inc found using ticker (EVH) now have 8 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 57 and 32 calculating the average target price we see 40.88. Now with the previous closing price of 26.79 this now indicates there is a potential upside of 52.6%. The 50 day moving average now sits at 31.63 and the 200 day MA is 30.87. The company has a market cap of $2,780m. You can visit the company''s website by visiting: https://www.evolenthealth.com [stock_market_widget type="chart" template="basic" color="green" assets="EVH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,242m based on the market concensus. Evolent Health, a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions.
Evolent Health: A Bit Complex, But Interesting (NYSE:EVH) 2022/11/21 10:05:22 Seeking Alpha
Evolent Health''s shares have seen a huge move higher on the back of a substantial deal. Click here to find out why the latest deal looks interesting.
This Analyst Is Bullish On Evolent Health''s Recent Deal, Calls ''Highly Strategic Acquisition'' 2022/11/18 20:01:32 Benzinga
Thursday after close, Evolent Health Inc (NYSE: EVH ) agreed to acquire Magellan Specialty Health, the specialty benefit management organization owned by Centene Corporation (NYSE: CNC ), for $650 million at the close plus additional contingent consideration of up to $150 million based on 2023 performance . William Blair is positive on the acquisition and believes this is consistent with management''s prior commentary that Evolent would consider strategic assets … Full story available on Benzinga.com
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday''s Mid-Day Session 2022/11/18 18:15:48 Benzinga
Gainers PaxMedica, Inc. (NASDAQ: PXMD ) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital. Satixfy Communications Ltd. (NYSE: SATX ) rose 53.2% to $79.20. 1847 Holdings LLC (NYSE: EFSH ) gained 27.3% to $2.0252. 1847 Holdings recently posted Q3 sales of $14.47 million. IVERIC bio, Inc. (NASDAQ: ISEE ) shares surged 25% to $21.54 after the company announced the FDA has granted breakthrough therapy designation for avacincaptad pegol for geographic atrophy. Clearfield, Inc. (NASDAQ: CLFD ) climbed 24.1% to $115.45 after the company reported better-than-expected Q4 results. Yatra Online, Inc. (NASDAQ: YTRA ) shares jumped 24.1% to $2.6299. Yatra Online''s Indian subsidiary, Yatra Online Limited, received the final observation from the Securities and Exchange Board of India. The company also announced that it will report its Q2 financial results on Tuesday, November 29, 2022. Conformis, Inc. (NASDAQ: CFMS ) gained 23.6% to $1.9540.